Effects of Different Early Intensive Therapies on Long-term β-cell Function
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 264 participants.
Also called NCT01471808
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 264 participants
- Sponsor
- Registry
-
NCT01471808
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT01471808. Randomized; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2018-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Different Early Intensive Therapies on Long-term β-cell Function
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- CSII
- Intervention (Drug)
- CSII, Metformin, Pioglitazone
- Intervention (Drug)
- CSII, Sitagliptin
- Lead sponsor
- Sun Yat-sen University
- Collaborator
- Nanfang Hospital, Southern Medical University
- Collaborator
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Collaborator
- Peking University Shenzhen Hospital
- Collaborator
- First People's Hospital of Foshan
Record details
- Record id
cardio:ct-nct01471808- Content hash
8311dff1600aaea2d8b2d494d1a69c4d6566b6d39078928bedf605d5da728c4d